Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY1A | P0DUB6 | 7/20 | 0.39 |
| ▸ | NQO2 | P16083 | 5/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | EPRS1 | P07814 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29856307 | 0.84 | MAPT (0.51) | AMY1ANQO2MAPTKDM4EMAPK1 | |
| SCHEMBL29856332 | 0.79 | NQO2 (0.46) | AMY1ANQO2MAPTALDH1A1KMT2A | |
| SCHEMBL29856225 | 0.78 | NQO2 (0.50) | AMY1ANQO2MAPTACHEALDH1A1 | |
| SCHEMBL29856293 | 0.75 | NQO2 (0.50) | NQO2MAPTKDM4EMAPK1ACHE | |
| SCHEMBL29856269 | 0.75 | NQO2 (0.50) | NQO2MAPTKDM4EMAPK1ACHE | |
| SCHEMBL29856318 | 0.75 | NQO2 (0.42) | NQO2MAPTKDM4EALDH1A1KMT2A | |
| SCHEMBL29856223 | 0.72 | MAPT (0.57) | NQO2MAPTKDM4EACHEALDH1A1 | |
| SCHEMBL29857002 | 0.72 | KDM4E (0.34) | AMY1ANQO2MAPTKDM4EMAPK1 | |
| SCHEMBL29856316 | 0.71 | ALDH1A1 (0.46) | NQO2MAPTKDM4EMAPK1ACHE | |
| SCHEMBL11421482 | 0.70 | NQO2 (0.61) | NQO2MAPTKDM4EMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12060334-B2 | 3-substituted phenazine derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-08-13 | — | — | US | disclosed |
| US-20220289689-A1 | 3-SUBSTITUTED PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289689-A1 | 3-SUBSTITUTED PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | ROS1, NOX4, NOX5 | AMY1A 4605/4885NQO2 139/4885MAPT 3143/4885 |
| US-12060334-B2 | 3-substituted phenazine derivatives as antimicrobial agents | ROS1, NOX4, NOX5 | AMY1A 4605/4885NQO2 139/4885MAPT 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.